Measurement of the end-systolic pressure-volume relation using intraaortic balloon occlusion
US4877035A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Oct 12, 1988 |
| Grant date | Oct 31, 1989 |
| Priority date | — |
| Expiry date | Oct 12, 2008 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61B5/029
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
Novel, noninvasive in vivo methods and apparatus for measuring the end-systolic pressure-volume relation and deriving peak end-systolic elastance, E.sub.max, which do not alter intrinsic or reflex-stimulated cardiac contractility are disclosed. Afterload is varied by the controlled inflation of an intraaortic balloon catheter positioned in the ascending aorta. Balloon inflation is timed to transiently interrupt ventricular ejection at different times during the ejection phase, producing contraction at different ventricular volumes. Simultaneous measurements of left ventricular pressure and aortic volume during the occlusion sequence allows pressure vs. ejected volume loops to be generated, from which the slope of the end-systolic pressure-volume relationship, E.sub.max is determined. E.sub.max was measured in 6 Dorsett sheep with normal, enhanced, and depressed contractile states. In the normal states, E.sub.max ranged from 1.01 to 5.08 mmHg/ml in animals with body weights ranging from 23 to 32 kg. This data was not significantly different (p>0.05) from the E.sub.max -body weight curve compiled from other measurements of E.sub.max, After epinephrine infusion, E.sub.max increased fr…
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.